PH22017000889U3 - Sambong tablet as antihyperuricemic agent - Google Patents
Sambong tablet as antihyperuricemic agentInfo
- Publication number
- PH22017000889U3 PH22017000889U3 PH2/2017/000889U PH22017000889U PH22017000889U3 PH 22017000889 U3 PH22017000889 U3 PH 22017000889U3 PH 22017000889 U PH22017000889 U PH 22017000889U PH 22017000889 U3 PH22017000889 U3 PH 22017000889U3
- Authority
- PH
- Philippines
- Prior art keywords
- sambong
- tablet
- antihyperuricemic
- agent
- antihyperuricemic agent
- Prior art date
Links
- 230000002961 anti-hyperuricemic effect Effects 0.000 title abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 240000000572 Blumea balsamifera Species 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present utility model relates to herbal medicinal preparation more particularly to antihyperuricemic agent using sambong (Blumea balsamifera) leaves powder. Sambong tablet is made my compounding 66.00%w sambong powder, 26.40%w lactose, 6.65%w com starch paste, 6.65%w and 0.95%w magnesium stearate
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH2/2017/000889U PH22017000889U3 (en) | 2017-11-08 | 2017-11-08 | Sambong tablet as antihyperuricemic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PH2/2017/000889U PH22017000889U3 (en) | 2017-11-08 | 2017-11-08 | Sambong tablet as antihyperuricemic agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| PH22017000889Y1 PH22017000889Y1 (en) | 2019-04-22 |
| PH22017000889U1 PH22017000889U1 (en) | 2019-04-22 |
| PH22017000889U3 true PH22017000889U3 (en) | 2019-06-26 |
Family
ID=66329191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH2/2017/000889U PH22017000889U3 (en) | 2017-11-08 | 2017-11-08 | Sambong tablet as antihyperuricemic agent |
Country Status (1)
| Country | Link |
|---|---|
| PH (1) | PH22017000889U3 (en) |
-
2017
- 2017-11-08 PH PH2/2017/000889U patent/PH22017000889U3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH22017000889Y1 (en) | 2019-04-22 |
| PH22017000889U1 (en) | 2019-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550849A1 (en) | Spray-dried mixture of human milk oligosaccharides | |
| WO2018226622A8 (en) | Compounds for treating huntington's disease | |
| TWD173671S (en) | Communications headset | |
| PH12017502040B1 (en) | Oral care composition comprising calcium silicate | |
| WO2015019198A3 (en) | High potency pancreatin pharmaceutical compositions | |
| EP4327880A3 (en) | Solid state form of ribociclib succinate | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| HK1214519A1 (en) | Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof | |
| CA3056612A1 (en) | Analogs of deutetrabenazine, their preparation and use | |
| GB2514741A (en) | Composition for use as a paint binder | |
| PH12018502339A1 (en) | Oral care composition | |
| SA516370446B1 (en) | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation | |
| PH22017000889U3 (en) | Sambong tablet as antihyperuricemic agent | |
| PH12019502342A1 (en) | Oral care composition based on zinc oxide and calcium dihydrogen phosphate | |
| MX2022007874A (en) | Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof. | |
| WO2016126115A3 (en) | Pharmaceutical composition comprising pitavastatin or a pharmaceutically acceptable salt thereof, and valsartan or a pharmaceutically acceptable salt thereof | |
| MX2018011431A (en) | Skin restoration product. | |
| PH22019050055U1 (en) | A carrot-calamansi powder through spray-drying | |
| PH22017000838U1 (en) | COMPOSITION OF FISH (Scomber scombrus) PASTILLAS | |
| PH22019050057U1 (en) | A process of preparation of carrot-calamansi powder through spray-drying | |
| UA83911U (en) | Pharmaceutical product with anthitrombotic action | |
| PH22018000045U1 (en) | COMPOSITION OF KATMON (Dillenia philippinesis) POWDER | |
| MX2019004057A (en) | Oral care composition having enhanced appearance and form. | |
| SG10201702854SA (en) | Composition of collagen peptides and astaxanthin | |
| GEP20146164B (en) | Foulbroods therapeutic agent "vesta" |